MMP9 and breast cancer: And their cross-talk regulates hypoxia/reoxygenation (H/R) induces breast cancer progression and further regulates the expression of melanoma cell adhesion molecule (MelCAM) urokinase-type plasminogen activator (uPA) matrix metalloproteinase-9 (MMP-9) and VEGF (43).